ATNM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Actinium Pharmaceuticals Inc (ATNM) is not a strong buy at the moment for a beginner investor with a long-term focus. The technical indicators are neutral, options data shows low trading sentiment, and the company's financial performance is weak. There are no significant positive catalysts or recent news to support a strong entry point.
The MACD is positive and expanding, indicating a slight upward momentum. RSI is in the neutral zone at 72.732, and moving averages are converging, suggesting no clear trend. The stock is trading near its resistance level (R1: 1.253), which may limit further upside in the short term.
NULL identified. No recent news or significant insider/hedge fund activity.
Additionally, there is no recent congressional trading data or influential figure activity to support the stock.
In Q4 2025, revenue remained at 0 with no growth YoY. Net income dropped to -$5.94M (-10.70% YoY), and EPS declined to -0.19 (-9.52% YoY). Gross margin remained at 100%, showing no improvement.
No recent analyst ratings or price target changes available.
